Geron

$1.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-2.65%) Today
-$0.02 (-1.36%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Geron and other stocks, options, and ETFs commission-free!

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

CEO
John A. Scarlett
Employees
55
Headquarters
Foster City, California
Founded
1990
Market Cap
440.33M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.19M
High Today
$1.51
Low Today
$1.44
Open Price
$1.51
Volume
1.68M
52 Week High
$2.40
52 Week Low
$1.10

GERN Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 27, After Hours

You May Also Like

CLW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure